Stephen Berenson - 03 May 2023 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Director
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
03 May 2023
Net transactions value
$0
Form type
4
Filing time
05 May 2023, 16:10:31 UTC
Previous filing
01 May 2023
Next filing
23 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Award $0 +4,601 $0.000000 4,601 03 May 2023 Common Stock 4,601 $130.14 Direct F1
transaction MRNA Restricted Stock Units Award $0 +732 $0.000000 732 03 May 2023 Common Stock 732 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will become fully vested and exercisable on the earlier of May 3, 2024, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.
F2 The shares subject to this restricted stock unit award will vest in full on the earlier of May 3, 2024, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.